Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IDEAYA Biosciences (IDYA) Net Margin: 2020-2025

Historic Net Margin for IDEAYA Biosciences (IDYA) over the last 3 years, with Sep 2025 value amounting to 52.18%.

  • IDEAYA Biosciences' Net Margin was N/A to 52.18% in Q3 2025 from the same period last year, while for Sep 2025 it was -73.86%, marking a year-over-year change of. This contributed to the annual value of -4,671.07% for FY2024, which is 409622.00% down from last year.
  • IDEAYA Biosciences' Net Margin amounted to 52.18% in Q3 2025, which was up 102.53% from -2,059.11% recorded in Q4 2024.
  • Over the past 5 years, IDEAYA Biosciences' Net Margin peaked at 52.18% during Q3 2025, and registered a low of -2,059.11% during Q4 2024.
  • For the 3-year period, IDEAYA Biosciences' Net Margin averaged around -791.54%, with its median value being -670.02% (2023).
  • In the last 5 years, IDEAYA Biosciences' Net Margin skyrocketed by 13,271bps in 2022 and then plummeted by 99,035bps in 2024.
  • Over the past 5 years, IDEAYA Biosciences' Net Margin (Quarterly) stood at -620.16% in 2021, then plummeted by 3,730bps to -657.46% in 2022, then tumbled by 41,131bps to -1,068.77% in 2023, then plummeted by 99,035bps to -2,059.11% in 2024, then reached 52.18% in 2025.
  • Its Net Margin was 52.18% in Q3 2025, compared to -2,059.11% in Q4 2024 and -1,068.77% in Q4 2023.